| ATCa | Study populationb N (%) | Dementia diagnosesc | P-value | Clinical signsdof DLB | P-value | Age groupse | P-value | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Yes N (%) | No N (%) |  | 0–1 N (%) | 2–4 N (%) |  | ≤85 years N (%) | ≥86 years N (%) |  | |||
Antipsychotics | |||||||||||
 Any | N05A | 132 (21.6) | 102 (23.2) | 29 (18.8) |  | 93 (19.1) | 39 (31.5) | * | 71 (27.4) | 61 (17.4) | ** |
 Haloperidol |  | 42 (7.1) | 28 (6.6) | 14 (9.3) |  | 25 (5.3) | 17 (14.3) | ** | 23 (9.3) | 19 (5.5) |  |
 Risperidone |  | 57 (9.6) | 49 (11.5) | 8 (5.3) |  | 45 (9.5) | 12 (10.1) |  | 29 (11.7) | 28 (8.1) |  |
 Other f |  | 11 (1.9) | 9 (2.1) | 2 (1.3) |  | 7 (1.5) | 4 (3.4) |  | 6 (2.4) | 5 (1.5) |  |
Anxiolytics | |||||||||||
 Any | N05B | 336 (58.4) | 263 (61.7) | 73 (49.0) | * | 251 (54.8) | 85 (72.6) | *** | 136 (56.2) | 200 (60.1) |  |
 Oxazepam |  | 308 (53.6) | 248 (58.2) | 60 (40.3) | ** | 228 (49.8) | 80 (68.4) | *** | 125 (51.7) | 183 (55.0) |  |
 Diazepam |  | 44 (7.7) | 31 (7.3) | 13 (8.7) |  | 25 (5.5) | 19 (16.2) | *** | 22 (9.1) | 22 (6.6) |  |
Hypnotics/sedatives | |||||||||||
 Any | N05C | 234 (40.7) | 176 (41.3) | 58 (38.9) |  | 186 (40.6) | 48 (41.0) |  | 103 (42.6) | 131 (39.3) |  |
 Zopiclone |  | 189 (32.9) | 139 (32.6) | 50 (33.6) |  | 145 (31.7) | 44 (37.6) |  | 78 (32.2) | 111 (33.3) |  |
 Other g |  | 77 (13.4) | 67 (15.7) | 10 (6.7) | ** | 68 (14.8) | 9 (7.7) | ** | 39 (16.1) | 38 (11.1) |  |
Anti-depressants | |||||||||||
 Any | N06A | 290 (50.4) | 225 (52.8) | 65 (43.6) | ** | 233 (48.4) | 57 (60.6) | * | 129 (53.3) | 161 (48.3) |  |
 SSRI |  | 204 (35.5) | 156 (36.6) | 48 (32.2) |  | 157 (34.3) | 47 (40.2) |  | 88 (36.4) | 116 (34.8) |  |
 Mirtazapine |  | 127 (22.1) | 103 (24.2) | 24 (16.1) | * | 99 (20.6) | 28 (29.8) |  | 58 (24.0) | 69 (20.7) |  |
 Venlafaxine |  | 18 (3.1) | 14 (3.3) | 4 (2.7) |  | 15 (3.1) | 3 (3.2) |  | 13 (5.4) | 5 (1.5) | * |
 Other |  | 6 (1.0) | 4 (0.9) | 2 (1.3) |  | 4 (0.9) | 2 (1.3) |  | 2 (0.8) | 4 (1.2) |  |